(Q44457386)

English

Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia

scientific article published in December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

object named as

Matthew Cotten

5

0 references

3

object named as

Lucy Dorrell

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Hilton C. Whittle

6

object named as

Hilton Whittle

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

7

object named as

Assan Jaye

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sarah Rowland-Jones

2

object named as

Sarah L Rowland-Jones

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Beatrice O Ondondo

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Kevin Peterson

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

3549-3560

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Distinct profile of T cell activation in HIV type 2 compared to HIV type 1 infection: differential mechanism for immunoprotection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Polyfunctional T cell responses are a hallmark of HIV-2 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Full-length gag sequences of HIV type 1 subtype C recent seroconverters from Pune, India

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Distinct recognition of closely-related HIV-1 and HIV-2 cytotoxic T-cell epitopes presented by HLA-B*2703 and B*2705.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

T-immunogenic peptides are constituted of rare sequence patterns. Use in the identification of T epitopes in the human immunodeficiency virus gag protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from guinea-bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Molecular cloning and polymorphism of the human immune deficiency virus type 2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Differential Immunogenicity of HIV‐1 Clade C Proteins in Eliciting CD8+and CD4+Cell Responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

21 January 2018

Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

7 January 2021

based on heuristic

inferred from DOI database lookup

High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

7 January 2021

based on heuristic

inferred from DOI database lookup

CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

7 January 2021

based on heuristic

inferred from DOI database lookup

Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838759

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.200838759

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44457386&oldid=2024740002"